SciELO - Scientific Electronic Library Online

vol.20 issue11Usefulness of the digital holographic microscopy for the histomorphometric study of human red blood cellsEpidermoid carcinoma of conjunctiva in an elderly author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO



On-line version ISSN 1029-3019


GONZALEZ FERNANDEZ, Sandra et al. CM-95 solution magnetically treated as prevention and therapy of radiodermitis in patients with cancer. MEDISAN [online]. 2016, vol.20, n.11, pp.2354-2361. ISSN 1029-3019.

A descriptive and longitudinal cases and controls investigation, of 75 patients with cancer in different locations, admitted to "Conrado Benítez García" Teaching Provincial Cancer Hospital in Santiago de Cuba, in one year, was carried out to evaluate the effectiveness of the CM-95 solution magnetically treated in the prevention and treatment of radiodermitis, applied before and after the radiotherapy by means of topical and oral dose of 15 mL in the 24 members of the study group, as long as, in the control group (27 patients) the same solution was applied without magnetizing; the rest conformed a group (also control group) that didn't receive any of the solutions. In many of the cases the radiodermitis didn't appear and it was not necessary to interrupt the radiotherapy or its suspension time diminished in 7 days, while in the controls the clinical entity was more presented and the clinical course time to renew the radiations was of 15 and 23 days. Most of the patients of the study group improved the adverse effects of radiotherapy, as gastritis, rectitis, diarrheas, lack of appetite, acute distress, and they maintained the hematological parameters in the normal limits

Keywords : cancer; radiodermitis; radiotherapy; CM-95 solution; magnetic treatment.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License